(International Association for the Study of Lung Cancer) Today's press briefing at the IASLC 17th World Conference on Lung Cancer (WCLC) focused on active prevention, with researchers sharing results of clinical drug trials that have shown reduction in risk of disease progression among lung cancer patients. Abstracts and full versions of news releases for each topic covered are available, including the complete article on the AURA3 Trial that is published in today's New England Journal of Medicine.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2gMUIrI
No comments:
Post a Comment